Levophed

norepinephrine, the active ingredient in Levophed, is a sympathomimetic (vasopressor) presented as an injection for intravenous use. It is employed to raise blood pressure in patients with septic shock, cardiogenic shock, acute hypotension, and post‑cardiac surgery hypotension. GNH USA supplies Levophed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levophed acts on the sympathetic nervous system to restore vascular tone and cardiac output in critical‑care settings. - Septic shock: improves blood pressure and organ perfusion. - Cardiogenic shock: supports cardiac output when the heart fails to pump adequately. - Acute hypotension: rapidly raises systemic vascular resistance to prevent organ ischemia. - Post‑cardiac surgery hypotension: stabilises haemodynamics after operative procedures.

Levophed may cause a range of adverse reactions that require monitoring.

Common Side Effects: - Headache: mild to moderate discomfort. - Tachycardia: increased heart rate due to beta‑1 stimulation. - Arrhythmia: irregular heart rhythm, often transient. - Peripheral ischemia: reduced blood flow to extremities. - Nausea: occasional gastrointestinal upset. - Anxiety: heightened nervousness or restlessness.

Serious or Rare Side Effects: - Myocardial ischemia: reduced heart muscle blood flow. - Severe hypertension: dangerously high blood pressure. - Tissue necrosis at infusion site: local tissue death if extravasation occurs. - Life‑threatening arrhythmias: ventricular tachycardia or fibrillation. - Pulmonary edema: fluid accumulation in lungs. - Severe bradycardia: markedly slow heart rate.

Levophed requires careful clinical oversight because of its potent cardiovascular effects. - Blood pressure monitoring: continuous arterial line measurement is essential. - Cardiac monitoring: ECG should be observed for arrhythmias. - Dose titration: adjust infusion rate to achieve target pressure without overshoot. - Extravasation risk: avoid infiltration; stop infusion immediately if signs appear. - Coronary artery disease: use cautiously, as increased demand may provoke ischemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levophed can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Beta‑blockers: may blunt desired increase in cardiac output. - Tricyclic antidepressants: heightened risk of arrhythmias.

Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may require higher norepinephrine doses. - ACE inhibitors: additive blood pressure effects. - Diuretics: potential volume depletion influencing response. - Calcium channel blockers: may affect vascular tone. - Other catecholamines: cumulative sympathomimetic activity.